Africa faces a profound healthcare challenge, bearing a quarter of the world’s disease burden while producing only a tiny fraction of its own medicines. This heavy reliance on imported drugs creates costly and unreliable supplies, a vulnerability starkly exposed during the COVID-19 pandemic. The core of the issue lies in importing over 95% of the active pharmaceutical ingredients (APIs) that make medicines work. However, a promising shift is underway. A growing movement, supported by innovative companies and government partnerships, is championing local API production. By adopting modern technologies like continuous flow manufacturing, the continent can cut costs, create jobs, and build a self-reliant pharmaceutical industry. With strategic investments and a focus on skilled workforce development, a future where Africa manufactures its own affordable, essential medicines is finally within reach, promising a healthier and more secure future for all.
The Conversation
